Shenzhen - Delayed Quote CNY

Northeast Pharmaceutical Group Co., Ltd. (000597.SZ)

5.28
+0.09
+(1.73%)
At close: May 23 at 3:04:27 PM GMT+8
Loading Chart for 000597.SZ
  • Previous Close 5.19
  • Open 5.18
  • Bid 5.28 x --
  • Ask 5.29 x --
  • Day's Range 5.18 - 5.36
  • 52 Week Range 3.72 - 6.69
  • Volume 32,721,781
  • Avg. Volume 24,451,935
  • Market Cap (intraday) 7.546B
  • Beta (5Y Monthly) 0.30
  • PE Ratio (TTM) 18.86
  • EPS (TTM) 0.28
  • Earnings Date --
  • Forward Dividend & Yield 0.10 (1.93%)
  • Ex-Dividend Date May 23, 2024
  • 1y Target Est --

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biomedicine, and other businesses in China. It offers vitamin products, including vitamin C, vitamin B1, vitamin B6, and levocarnitine series; anti-infection products, such as fosfomycin series, azithromycin series, berberine hydrochloride, chloramphenicol, and other products; and reproductive system and sex hormone products comprising carboprost suppositories, carboprost tromethamine, dapoxetine hydrochloride, and levonorgestrel and tadalafil tablets. The company also provides nervous system products, such as piracetam series, levetiracetam series, vinpocetine, and other products; narcotics and narcotic-containing products, including morphine hydrochloride injection, pethidine hydrochloride injection, morphine hydrochloride tablets, oxycodone hydrochloride injection, and other products; anti-AIDS products comprising kedu/zidovudine tablets, kedu/zidovudine capsules, efavirenz tablets, zidolamid bivudine tablets, and other products; and in vitro biological diagnostic reagent products, such as HIV, HBV, HCV, HPV, and TB molecular diagnostic reagents. In addition, it offers general health products, including vitamin C powder, effervescent tablets, chewable tablets, solid drinks, glycosaminoglycan chondroitin sulfate collagen D3 calcium capsules, protein powder, probiotic powder, and other products. Further, the company provides Zhengchangsheng aluminum carbonate magnesium chewable tablets; Zhenxiwei compound proglumide and cimetidine tablets; amlodipine maleate; compound licorice series; narcotine syrup; Kefei, a compound codeine phosphate syrup; Xiaoke, a citronix tablets; acetaminophen tablets, pain-relieving tablets; metronidazole tablets; tinidazole tablets; paracetamol tablets; and other products. Additionally, it engages in medical distribution business. The company was founded in 1946 and is based in Shenyang, China.

www.nepharm.com.cn

5,964

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 000597.SZ

View More

Performance Overview: 000597.SZ

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000597.SZ
0.19%
SSE Composite Index (000001.SS)
0.10%

1-Year Return

000597.SZ
17.59%
SSE Composite Index (000001.SS)
7.44%

3-Year Return

000597.SZ
0.93%
SSE Composite Index (000001.SS)
6.40%

5-Year Return

000597.SZ
9.25%
SSE Composite Index (000001.SS)
19.00%

Compare To: 000597.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 000597.SZ

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    7.55B

  • Enterprise Value

    6.29B

  • Trailing P/E

    19.20

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.00

  • Price/Book (mrq)

    1.41

  • Enterprise Value/Revenue

    0.84

  • Enterprise Value/EBITDA

    10.45

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.17%

  • Return on Assets (ttm)

    1.86%

  • Return on Equity (ttm)

    7.36%

  • Revenue (ttm)

    7.51B

  • Net Income Avi to Common (ttm)

    388.54M

  • Diluted EPS (ttm)

    0.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.39B

  • Total Debt/Equity (mrq)

    38.03%

  • Levered Free Cash Flow (ttm)

    -1.66B

Research Analysis: 000597.SZ

View More

Company Insights: 000597.SZ

Research Reports: 000597.SZ

View More

People Also Watch